Lord, Abbett & Co’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-317,429	Closed	-$46.3M	–	633
2022 Q2	$46.3M	Sell	317,429 -135,673	-30%	-$19.8M	0.16%	179
2022 Q1	$53.7M	Buy	453,102 +174,775	+63%	+$20.7M	0.14%	204
2021 Q4	$38.4M	Buy	278,327 +178,327	+178%	+$24.6M	0.09%	305
2021 Q3	$13.9M	Buy	+100,000	New	+$13.9M	0.03%	470